Language
Language
On June 10, 2025, Faciox Inc. held a grand opening ceremony for its R&D center at the Baogao Science and Intellectual Park in Xindian District, New Taipei City. The company officially launched its new smart manufacturing and R&D base, which focuses on the innovation and application of oxygen concentrators and respiratory therapy devices. This event symbolizes a new milestone for Faciox Inc., advancing its R&D and internationalization within the medical device field.
Many distinguished guests and scholars attended the ceremony to offer their congratulations, including New Taipei City Deputy Mayor Liu He-ran, Deputy Commissioner of the Economic Development Department Chen Mei-hsiu, Legislator Luo Ming-cai, Executive Yuan Policy Advisor Liu De-zong, and Chairman of the National Federation of Medical Device Commercial Associations Chen Yao-bin. They all jointly witnessed this significant milestone that will promote the development of smart healthcare in Taiwan.
As a local medical device brand with over 20 years of dedication to the respiratory care field, Faciox Inc. has invested tens of millions to build the Baogao R&D Center. The center integrates AI, fluid simulation technology, and digital manufacturing capabilities to continue promoting the innovative design and high-quality production of Made-in-Taiwan (MIT) oxygen devices. The center will serve as the R&D base for portable and home-use oxygen concentrators, strengthening product testing and regulatory verification, and accelerating global market expansion.
General Manager Wang Ren-jie stated, "The Baogao R&D Center is not just an upgrade of our hardware facilities; it also represents our continued commitment to Faciox Inc.'s brand mission of 'caring for health throughout the entire lifespan.' By combining resources from industry, government, academia, and research, we hope to promote more smart medical products that are closer to clinical needs and suitable for an aging society.
